Archive for proven sires

August 2025 Proofs: New Kings, Big Swings, and What It Means for Your Herd

Bulls losing 102 points overnight while proven sires gain $2,400/cow advantage? August’s genomic chaos changes everything we know.

EXECUTIVE SUMMARY

The August 2025 genetic evaluations reveal a critical shift in the dairy industry, as the proven reliability of daughter-backed sires increasingly outshines the volatile promise of their genomic counterparts. This trend is highlighted by major ranking changes, including Stantons Remover PP leaping to the #1 proven spot in Canada, while genomic bulls like Cookiecutter Hadley-ET experienced dramatic drops. The displacement of established sires like Genosource Captain in the UK further signals a rapid industry shift towards functional traits, such as health and efficiency. This dynamic underscores a move by breeders to prioritize real-world economic performance, exemplified by GENOSOURCE RETROSPECT-ET’s dominance in the US Net Merit rankings, leading to breeding strategies that now favor the stability of proven genetics.

KEY CHANGES

  • Stantons Remover PP: The biggest mover, leaping from #7 to become the new #1 proven sire in Canada (LPI) after his first daughters validated his genomic potential.
  • Cookiecutter Hadley-ET: A prime example of genomic volatility, going from #2 to #10 in the Italian genomic rankings in a single evaluation cycle.
  • OCD Trooper Sheepster: Emerged as the new #1 daughter-proven sire in the UK (£PLI), showcasing a desirable combination of production and a high lifespan improvement.
  • GENOSOURCE RETROSPECT-ET: The new leader for Net Merit ($NM) in the US, headlining Genosource’s complete domination of the economic-focused index.
  • Genosource Captain: A significant change, this former industry-leading sire dropped to fifth place in the UK and 3rd place in the US, highlighting the rapid genetic progress and shifting priorities towards health and efficiency traits.
  • Evenstar & Pennywise: A pair of “twin” sires who became the new #1 genomic leaders in Germany ($RZG), both achieving an elite score of 164.
  • Peak Spellbound-ET: Surged to become the new #1 genomic sire in Italy ($gPFT), noted for his exceptional component percentages that appeal to the cheese market.

The August 2025 genetic evaluations have delivered the most dramatic ranking reshuffles we’ve seen in years, with proven sire Stantons Remover PP leaping from #7 to #1 in Canada, while Italian genomics swung by 100+ points in single evaluations. The real story? Proven reliability is increasingly outperforming genomic promises as economic pressures force progressive breeders to prioritize profitable genetics over flashy TPI numbers.

Look, I’ve been watching genetic evaluations for over two decades, and what just dropped in August 2025 has me scratching my head in the best possible way. We’re seeing ranking shifts that would’ve been unthinkable just a few years ago—and the implications for your breeding program are massive.

The thing that’s really got my attention isn’t just the new leaders (though they’re impressive), it’s this growing tension between what genomics promise and what proven bulls actually deliver. And frankly, some of the volatility we’re seeing should prompt every breeder to pause before they become too aggressive with unproven genetics.

The Great Genomic Reality Check—And Why It Matters to Your Bottom Line

Here’s what’s happening across the major Holstein markets, and it’s telling a story that every progressive breeder needs to understand. We’re looking at the United States, Canada, the UK, Germany, and Italy—basically the genetic powerhouses that drive most of our industry decisions.

The pattern that’s emerging? Genomic predictions are becoming increasingly volatile, while proven bulls are demonstrating the kind of consistency that actually pays the bills. Take what just happened in Italy—Cookiecutter Hadley-ET dropped from #2 to #10 genomic, losing 102 points in one evaluation cycle. That’s not a small adjustment; that’s a complete reversal of fortune.

Meanwhile, proven sire ZFZ Crisalis RF gained 29 points, strengthening his position as #1. The guy has thousands of daughters, actually milking in real barns, dealing with real feed costs and real heat stress. There’s something to be said for that kind of validation.

What really drives this home is the German comparison. Their genomic leaders, Evenstar and Pennywise, both reached RZG 164—that’s a 17-point advantage over proven leader Zivet, who reached RZG 147. Now, if you’re doing the math on lifetime profit, that gap represents serious money… if the predictions hold true.

Marco Winters from AHDB put it perfectly when he looked at the UK situation: “The six new graduates in the top 10 already have around 7,000 heifers registered in UK milk-recorded herds, with some now milking. Their proven £PLI values deviate by just one point on average from their earlier genomic predictions.”

That’s the kind of validation that makes you feel good about using genomics early. But here’s the thing—not every market is showing that kind of accuracy.

North America: Where Economic Reality Meets Genetic Hype

The United States: Genosource’s Economic Domination

What’s fascinating about the US August proofs is how they reveal a fundamental shift toward economic reality. Sure, BEYOND HI-LEVEL-ET claimed the #1 genomic spot at +3539 TPI, but honestly, that’s not the story that’s going to matter to your milk check.

The real story is how Genosource has completely taken over the Net Merit rankings. I mean completely. GENOSOURCE RETROSPECT-ET leads at +1317 NM$, followed by his stable mates GENOSOURCE ENDURANCE-ET (+1233NM) and GENOSOURCE PURDY-ET (+1222 NM$).

This isn’t a coincidence—this is systematic breeding for traits that actually make money rather than chasing TPI points that look good on paper but don’t always translate to profitability. And with feed costs where they are in 2025, that focus on economic merit is becoming non-negotiable.

In the proven ranks, SDG CAP GARZA-ET is leading at +3488 TPI with 98% reliability. What I like about Garza is his balance—+146 lbs fat, +53 lbs protein, and +3.7 PL. Those are the kind of numbers that keep operations profitable when everything else goes sideways.

Canada: The Remover Revolution (And What It Really Means)

Now this is where August got really interesting. Stantons Remover PP made this spectacular jump from #7 in April to #1 in August (+3897 LPI). That’s not just a statistical blip—this bull’s backed by 234 daughters across 32 herds, which means we’re looking at real-world validation of genomic predictions.

What strikes me about Remover is his profile. He’s not just high-scoring, he’s balanced in exactly the ways that Canadian producers need as replacement costs keep climbing. The durability traits are there, the production is solid, and crucially, he’s proving himself in diverse management systems across the country.

The genomic young sire category is where things get really exciting, though. OCD Milan-ET leads at +4118 GPA LPI, and his numbers tell a story: +638 Milk, +108 Fat, plus strong type (+10 Mammary System, +6 Feet & Legs). This combination of production and structural soundness is exactly what the Canadian industry has been selecting for—cattle that can handle our diverse climate and management challenges.

European Markets: The Functional Excellence Revolution

United Kingdom: When Genomic Predictions Actually Work

The UK market gave us probably the strongest validation of genomic accuracy we’ve seen recently. Six new daughter-proven sires graduated into the top 10 PLI positions, and here’s the kicker—their proven values are matching their genomic predictions almost perfectly.

OCD Trooper Sheepster emerged as the new proven leader at £779 PLI. His production numbers are impressive (47.8kg fat, 35.7kg protein), but what really catches my attention is the +113-day lifespan improvement. With replacement costs exceeding £ 2,000 per animal, longevity traits like these are becoming the difference between profit and loss.

The genomic leader, Peak AltaValuepack, at £877 PLI, shows even stronger longevity (+122 days) while maintaining solid production (+785kg milk). This represents what I think is the modern ideal—comprehensive genetic merit that addresses both production and durability.

What’s particularly noteworthy is how Genosource Captain dropped to fifth place (£723 PLI) despite having over 2,000 UK milking daughters. This displacement illustrates how rapidly genetic progress can transform breeding hierarchies when functional traits take precedence over other traits. The Captain has been a reliable choice for years, but the industry’s moving toward health, fertility, and efficiency traits faster than many expected.

Germany: Precision Breeding at Its Finest

German evaluations consistently demonstrate why their breeding program is considered world-class. Proven leader Zivet commands RZG 147 through this impressive balance: +1,971 kg milk, +88 kg fat, +86 kg protein, combined with functional traits (RZN 121, RZGes 113) that actually work in commercial settings.

The genomic sphere produced these twin leaders in Evenstar and Pennywise, both at RZG 164. Evenstar’s projections (+2,090 kg milk, +120 kg fat, +69 kg protein, RZN 134) position him as a premium choice for operations serious about maximizing both production and longevity.

What’s interesting is how Red Holstein genetics keep showing up in top rankings. Ginger leads proven sires at RZG 143 with +2,638 kg milk through 510 daughters. In genomics, Schach achieved RZG 161. This demonstrates continued genetic progress in color variants—something that’s becoming increasingly important as producers seek ways to differentiate their cattle.

Italy: The Volatility That Should Worry Everyone

The Italian evaluations provided the starkest illustration of genomic volatility I’ve seen. Peak Spellbound-ET surged to #1 genomic position at 5458 gPFT—he’s an Overdrive son showing impressive components (+1.07% fat, +0.54% protein) that appeal to Italy’s cheese-focused industry.

But here’s what should concern every breeder: the dramatic swings in genomic rankings. Bulls gaining or losing 100 points or more in a single evaluation raise serious questions about reliability. This underscores why the Italian proven bull rankings, where ZFZ Crisalis RF maintains steady leadership at 5169 gPFT, provide such important stability.

The Italian ICS-PR€ index tells another story entirely. Smartie P-ET leads with 1398 ICS-PR€, demonstrating the economic reality that in value-added dairy systems, components matter more than volume. This is particularly relevant as more operations explore premium markets.

The Trends That Are Reshaping Everything

Health and Longevity: No Longer Optional

What’s becoming increasingly clear across all markets is that health and longevity traits are no longer nice-to-have features—they’re essential for profitability. PROGENESIS WATCHMAN’s elite 8.6 Health Index represents the kind of defensive genetics that operations need against rising veterinary costs.

The UK’s emphasis on HealthyCow values and Germany’s focus on RZGes scores reflect an industry-wide recognition that profitable cows must first be healthy cows. This isn’t just about animal welfare (though that matters), it’s about economic survival in an environment where every sick cow threatens your bottom line.

Component Production: The New Economic Reality

The shift toward fat and protein production rather than volume alone is evident everywhere you look. German proven sire Ginger’s +2,638 kg milk production demonstrates that volume still matters, but bulls like Peak Spellbound-ET, with +1.07% fat, are capturing attention in component-focused markets.

This trend makes sense when considering where milk prices are headed. Component premiums are becoming more significant, and operations that can deliver high-quality fat and protein are seeing better returns than those focused purely on volume.

Polled Integration: Finally Happening Seamlessly

Polled genetics are showing up in top rankings without the performance compromises we used to see. Germany’s Create P achieving RZG 161 and Canada’s Vogue A2P2-PP maintaining +15 CONF demonstrate successful integration of polled traits into elite genetic packages.

This matters because consumer pressure around dehorning isn’t going away, and having polled options that don’t sacrifice performance removes a major management headache.

The Bloodline Concentration Problem

Here’s something that should concern everyone: the dominance of specific sire lines across multiple countries. Overdrive sons appear in top rankings across markets, while Genosource genetics dominate US economic merit rankings.

This concentration delivers short-term genetic progress, but it’s creating long-term risks to breed adaptability. We’ve seen this movie before with other breeds, and it doesn’t end well if we’re not careful about maintaining genetic diversity.

Economic Pressures Driving Everything

Feed Efficiency: The Make-or-Break Trait

With feed costs still elevated in 2025, bulls showing superior feed conversion are becoming premium choices. The UK’s emphasis on Maintenance Index scores and Italy’s ICS-PR€ rankings reflect an industry that can no longer afford inefficient genetics.

Genosource Captain’s Feed Advantage, with a +255, exemplifies why these traits matter so much. When margins are this tight, feed efficiency often determines profitability more than raw production numbers. This is basic math that every operation needs to understand.

Replacement Costs: Why Longevity Pays

Rising replacement heifer costs are elevating longevity traits to critical importance. OCD Trooper Sheepster’s +113 days lifespan improvement and Peak AltaValuepack’s +122 days longevity represent real economic value when replacements cost $2,000+ per animal.

The math here is straightforward—every additional lactation from a cow represents thousands of dollars in value. Operations that ignore longevity traits in favor of short-term production are essentially choosing to hemorrhage money on replacement costs.

What This Means for Your Breeding Strategy

The Portfolio Approach (Because Balance Matters)

The volatility we’re seeing suggests genetic diversification rather than relying on a single bloodline. Successful operations are adopting portfolio approaches—combining proven reliability with selective use of high-potential genomics. My recommendation? Build genetic portfolios with 60-70% proven sires and 30-40% genomic young sires, adjusting based on your risk tolerance and genetic progress objectives. This captures advancement while maintaining reliability.

Market-Specific Selection (One Size Doesn’t Fit All)

Each market’s payment systems and management conditions require tailored strategies. Italian producers focused on cheese production, with weight component percentages, differently than Canadian operations that sell fluid milk.

UK producers must balance production with stringent health and welfare requirements.

This means you can’t just follow rankings blindly—you need to understand what traits actually drive profitability in your specific market situation.

Timing Genomic Adoption (When to Jump, When to Wait)

The UK’s validation of genomic predictions through proven daughters provides confidence for early adoption of superior young sires. However, the Italian experience suggests that extensive use of unproven genetics carries a substantial risk.

Successful breeders are adopting measured approaches—using genomic bulls selectively while maintaining core breeding programs on proven genetics. It’s about being progressive without being reckless.

Looking Forward: The Real Strategic Imperatives

What the August 2025 evaluations really reveal is that the industry is striking a balance between the promise of genomics and economic reality. The winners aren’t chasing the highest TPI or PLI scores—they’re building profitable, sustainable herds adapted to their specific conditions.

Success belongs to breeders who strategically combine proven genetics as their foundation with selective genomic advancement. The future isn’t about choosing between proven and genomic selection—it’s about leveraging both approaches to create cattle that thrive in an increasingly challenging environment.

The real winners are already emerging, and they’re not just showing up in rankings. They’re showing up in milk checks and bottom lines of operations that have learned to balance genetic potential with economic reality. Because at the end of the day, that’s what actually matters in this business.

Read complete breakdowns for each country here:

Join the Revolution!

Join over 30,000 successful dairy professionals who rely on Bullvine Weekly for their competitive edge. Delivered directly to your inbox each week, our exclusive industry insights help you make smarter decisions while saving precious hours every week. Never miss critical updates on milk production trends, breakthrough technologies, and profit-boosting strategies that top producers are already implementing. Subscribe now to transform your dairy operation’s efficiency and profitability—your future success is just one click away.

NewsSubscribe
First
Last
Consent

Stud Wars: April 2025 – The Genetic Force Awakens

Sexing Tech’s 40% NM$ empire vs ABS’s 68% polled coup – the dairy genetics galaxy will never be the same.

The battle for Holstein genetic supremacy rages on in a galaxy not so far away. As we unveil the April 2025 sire share analysis, prepare to embark on an epic journey through the stars of bovine excellence. From the rise of a new empire to the resilience of the Rebel Alliance, our tale is one of innovation, strategy, and the relentless pursuit of genetic perfection. So, grab your lightsabers or your iPhone and join us as we explore the forces reshaping the Holstein universe.

Methodology: Expanding the Genetic Battlefield

In our analysis of the Holstein genetic landscape, we deliberately expanded our battlefield to include the top 200 sires for TPI, NM$, and PTAT rankings. This methodological choice reflects the incredibly tight competition at the elite level of Holstein genetics in 2025. As our data reveals, merely 31 NM$ points separate the 100th from the 200th ranked bull, with even smaller gaps between consecutive rankings further down the list. These minimal differences represent mere “parsecs” in the vast genetic universe, yet they can significantly impact how market dominance is measured. By widening our scope to 200 sires per category, we capture a more comprehensive and accurate representation of each stud’s true genetic firepower, preventing the distortion that would occur if we limited our analysis to a smaller elite force. This expanded approach better reflects the practical reality faced by dairy farmers, who often select beyond the top 100 to find bulls with the specific trait combinations best suited for their herds. For R&W PTAT and Polled NM$ are still just top 100, as the variance in those lists is much greater. (All sires must be over 1 year of age and have a NAAB code as active)

The TPI Saga: A New Empire Rises

Genomic TPI: The Force Awakens

StudSire Share (%)
Sexing Technologies39.5%
Select Sires21.5%
Semex Alliance15.0%
GENEX8.0%
Others16.0%

In a stunning display of genetic prowess, Sexing Technologies has emerged as the new Galactic Empire of genomic TPI, increasing its sire share from 20% in June 2024 to an impressive 39.5% in April 2025. This 19.5% surge represents a seismic shift in the balance of power. The once-dominant Select Sires has seen its influence wane, dropping from 32% to 21.5%, while Semex Alliance’s share has contracted from 24% to 15%. GENEX has entered the fray as a new contender, capturing 8% of the sires.

Proven TPI: The Old Guard Stands Firm

StudSire Share (%)
Sexing Technologies25.5%
Select Sires18.0%
Alta Genetics13.5%
Semex Alliance13.0%
Others30.0%

The proven TPI battlefield shows Sexing Technologies consolidating its power, increasing from 20% to 25.5%. Select Sires maintains a strong position, while Alta Genetics has emerged as a formidable new player, capturing 13.5% of the sires. The “Others” category, representing the diverse rebel forces, still holds a 33.5% share of sires.

Total TPI: The New Balance of Power

StudSire Share (%)
Sexing Technologies32.5%
Select Sires19.8%
Semex Alliance14.0%
Alta Genetics9.0%
Others24.7%

The combined TPI rankings reveal Sexing Technologies’ ascendancy to the throne, with their share skyrocketing from 21% to 32.5%. Once the ruling dyad, Select Sires and Semex Alliance are now in a pitched battle for second place. Alta Genetics has joined the fray as a significant force, while the “Others” have seen their collective influence diminish.

The NM$ Chronicles: Economic Battles in the Genetic Galaxy

Genomic NM$: The Imperial Takeover

StudSire Share (%)
Sexing Technologies53.5%
GENEX11.5%
ABS Global11.0%
Semex Alliance8.0%
Others16.0%

In a move that would make Emperor Palpatine proud, Sexing Technologies has seized control of the genomic NM$ sector, their share of sires exploding from 20% to an overwhelming 53.5%. This 33.5% increase represents the most dramatic power grab in our saga. Semex Alliance, once a significant power, has seen its influence plummet from 34% to a mere 8%. GENEX and ABS Global have emerged as new contenders in this economically crucial battleground.

Total NM$: The New Economic Order

StudSire Share (%)
Sexing Technologies26.5
ABS Global16.5%
Alta Genetics12.0%
GENEX11.5%
Others33.5%

The total NM$ rankings show Sexing Technologies’ dominance extending across the economic landscape, with their share holding steady at 26%. ABS Global has staged a remarkable comeback, rising from obscurity at 2.5% to claim 16.5% of the sires. Alta Genetics and GENEX have also secured strong positions in this vital index.

Total NM$ – The Economic Theater

StudSire Share (%)
Sexing Technologies40.0%
Alta Genetics11.8%
ABS Global11.5%
GENEX11.5%
Others25.2%

In the economic theater of the Stud Wars, Sexing Technologies has executed a Death Star-level takeover of the NM$ galaxy, crushing rivals to claim 40% share of sires—a stunning 14% surge since 2024. ABS Global emerges as the rebellion’s surprise hero, blasting from 2.5% to 11.5% dominance, while Alta Genetics (11.8%) and GENEX (11.5%) form a fragile alliance to hold the line. The “Others” faction—scattered rebel forces—clings to 25.2% territory, their dwindling influence underscoring the Empire’s tightening grip on profit-driven genetics. For dairy commanders, this consolidation signals a new era: choose your fleet wisely, for the NM$ arms race determines galactic profitability.

The PTAT Rebellion: Diversity in the Face of Empire

Genomic PTAT: A New Hope for the Alliance

StudSire Share (%)
Semex Alliance21.0%
ASCOL13.5%
Blondin Sires12.5%
Select Sires10.0%
Others48.5%

In a twist worthy of a Jedi mind trick, Semex Alliance has strengthened its position in genomic PTAT, increasing from 12% to 21%. ASCOL has emerged as a new power with a 13.5% share of sires. Sexing Technologies’ influence has waned in this sector, dropping from 24% to 7%. The “Others” category controls nearly half the sires, representing the diverse rebel forces.

Proven PTAT: The Rise of Unexpected Heroes

StudSire Share (%)
Blondin Sires, Inc.15.5%
ASCOL10.0%
Alta Genetics9.0%
Sexing Technologies8.0%
Others57.5%

In a plot twist rivaling the revelation of Luke’s parentage, Blondin Sires, Inc. has emerged from obscurity to lead the proven PTAT category with a 15.5% share of sires. Sexing Technologies has dramatically reduced its influence from 24% to 8%. The “Others” category, representing the diverse rebel alliance, controls 57.5% of the market.

Total PTAT Share: The Rebel Alliance Strikes Back

StudSire Share (%)
Blondin Sires, Inc.14.0%
Semex Alliance13.0%
ASCOL12.0%
Select Sires9%
Others52%

In the conformation galaxy’s last stand against genetic consolidation, Blondin Sires, Inc. (14%) emerges as the Luke Skywalker of type traits, leading a ragtag alliance with Semex Alliance (13%) and ASCOL (12%) against the Empire’s homogenizing forces. The “Others” faction dominates 52%—the largest rebel territory—proving PTAT remains the Hoth of diversity, where niche studs wield lightsabers of specialized genetics. This starkly contrasts with NM$’s imperial rule, offering dairy commanders a strategic dilemma: join the rebellion’s type-trait insurgency or succumb to the Dark Side of economic consolidation.

Specialty Forces: Niche Battles in the Genetic Galaxy

Red & White PTAT: The Colored Rebellion

StudSire Share (%)
Semex Alliance38.0%
Select Sires18.5%
ABS Global11.0%
Sexing Technologies7.5%
Others25.0%

Semex Alliance has significantly strengthened its hold on the Red & White PTAT sector, increasing from 21% to 38%. This 17% surge represents a significant shift in this specialized battleground. Select Sires has seen its influence decrease from 27% to 18.5%, while ABS Global and Sexing Technologies maintain smaller but significant footholds.

Polled NM$: The Horn-Free Revolution

StudSire Share (%)
ABS Global68.5%
Select Sires9.0%
Sexing Technologies7.5%
Semex Alliance4.0%
Others11.0%

In a move that would make even the Death Star envious, ABS Global has seized control of the Polled NM$ sector, their sire share skyrocketing from 22% to an overwhelming 68.5%. This 46.5% increase represents our entire saga’s most dramatic power grab. Semex Alliance has seen its influence in this sector nearly obliterated, dropping from 22% to 4%.

The Final Frontier: Overall Sire Dominance

Total Genomic Sires: The Clone Army’s Last Stand

StudSire Share (%)
Sexing Technologies23.0%
ABS Global19.7%
Semex Alliance17.2%
Select Sires13.1%
Others26.9%

In the genomic theater of the Stud Wars, Sexing Technologies’ clone army (23%, 230 sires) faces a blitzkrieg from ABS Global’s 19.7% surge (197 sires) – a Vader-esque power grab since 2024. The Rebel Alliance, led by Semex Alliance (17.2%, 172 sires) and Select Sires (13.1%, 131 sires), battles alongside scattered resistance (26.9%, 268 sires), while mid-tier factions like GENEX (4.2%) exploit cracks in the Empire’s armor. Yet Sexing’s genomic grip pales against their Death Star-level 53% NM$ dominance, revealing a strategic vulnerability: will rebels seize this opening, or will the Empire’s SNP chips crush all resistance? The fate of genetic diversity hangs in hyperspace.

Total Proven Sires: The Rebellion’s Hidden Fleet

StudSire Share (%)
Sexing Technologies20.0%
Alta Genetics13.0%
Select Sires12.3%
Semex Alliance9.3%
Others45.4%

While Sexing Technologies commands 20% of proven genetics (120 sires), their Death Star-like genomic dominance cracks here—Alta Genetics (13%, 78) and Select Sires (12.3%, 74) lead a rebel stronghold, flanked by Semex Alliance (9.3%, 56). The real threat to imperial forces? A fragmented “Others” armada (45.4%, 273 sires) comprising 28 studs—ABS Global (8%, 48) and GENEX (6.7%, 40) lurk as sleeper cells, Blondin Sires (5.3%, 32) deploy stealth specialists in PTAT skirmishes, and CRV (4.3%, 26) operates a European foreign legion. For dairy rebels, this sector offers hope: JLG (3.5%, 21) and ASCOL (3.3%, 20) prove small forces matter. But beware—Sexing’s 20% beachhead signals genomic tactics invading proven territory. The rebellion must rally or face assimilation.

Total Overall Share of Sires

StudSire Share (%)
Sexing Technologies22%
ABS Global15%
Semex Alliance14%
Select Sires13%
Others36%

A new order has emerged as the dust settles on this latest chapter of the Galactic Stud Wars. Sexing Technologies has become the dominant force, maintaining its overall share of sires from 22%. ABS Global has staged a remarkable comeback, surging from 9% to 15% share of sires. The once-dominant Select Sires has seen its influence wane but remains a significant player.

The Bottom Line: The Force Awakens in Holstein Genetics

As we conclude this epic tale of genetic warfare, one thing is clear: the force of progress is stronger than ever. The dramatic shifts we’ve witnessed – from Sexing Technologies’ ascension to galactic dominance to ABS Global’s mastery of polled genetics – herald a new era in dairy breeding.

For the Jedi Masters of dairy cattle breeding and the Padawans of genomic matings alike, these changes offer both challenges and opportunities. Consolidating power among the top AI companies may seem daunting, but remember: even a small farm can strike a mighty blow for progress in genetics.

As we look to the future, one can’t help but wonder what the next episode will bring. Will we see the return of the “Others,” striking back against the genetic empires? Or will new alliances form, creating even more potent combinations of traits and technologies?

Whatever lies ahead, one thing is sure: the saga of Holstein genetics is far from over. May the Force be with you as you navigate these exciting times in dairy breeding. And remember, in the immortal words of Master Yoda, “Do or do not. There is no try” – especially when building the perfect herd.

Key Takeaways

  • Sexing Tech’s genomic NM$ dominance (+33.5%) reshapes profit genetics
  • ABS Global’s polled coup (+46.5%) creates near-monopoly in horn-free sires
  • PTAT remains rebellion territory (51.7% “Others”) favoring specialty studs
  • Market consolidation crushes small players (“Others outside the top 5” shrinks from 30% → 12.8%)
  • Strategic breeding now requires balancing genomic powerhouses vs niche specialists

Executive Summary

The April 2025 Holstein genetics showdown reveals seismic power shifts: Sexing Technologies dominates genomic sire lists (53.5% NM$), while ABS Global conquers polled genetics with 68.5% control. Traditional leaders like Select Sires face decline, while niche players thrive in PTAT’s fragmented battlefield (45% “Others”). Market consolidation accelerates, with top 4 companies now controlling 87% of sire influence. Dairy producers must navigate this new galactic order where genomic prowess battles proven reliability.

Learn more

Join the Revolution!

Join over 30,000 successful dairy professionals who rely on Bullvine Daily for their competitive edge. Delivered directly to your inbox each week, our exclusive industry insights help you make smarter decisions while saving precious hours every week. Never miss critical updates on milk production trends, breakthrough technologies, and profit-boosting strategies that top producers are already implementing. Subscribe now to transform your dairy operation’s efficiency and profitability—your future success is just one click away.

NewsSubscribe
First
Last
Consent

Send this to a friend